Chimeric: Media Thread, page-618

Milcom, the market like you got no idea. And I am not an expert either but when the FDA invites CHM to go for a rego trial then the trial numbers for that particular cancer type are sufficient. Nobody said that CHM 1101 cures GBM, so far it just keeps it at bay or slows down the deadly progress. But the technology is new and with the optimal biological dose now being administered and no side effects recorded the outlook for even better results is bright. Plus, the current drugs / treatments are used for early stages, CHM 1101 has been applied to patients being severely impacted and going through 3-4 other types of treatment before CHM 1101.

Again, when the FDA says " It is great, more of that! " I stick with their assessment and not yours or the ASX'. But if you still have doubts, then please educate the FDA, pretty sure they will value your suggestions.

The sp could go as low as 0.1c or move to above $1 tomorrow, nothing is impossible when ASX participants are involved.

GLTA